administration of second dose of vaccine product containing only bordetella pertussis and clostridium tetani and corynebacterium diphtheriae and haemophilus influenzae type b and hepatitis b virus antigens
percutaneous embolization of nasal blood vessel using fluoroscopic guidance with contrast